This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Helen of Troy (HELE) Gains on Leadership Brands, Hurt by Costs
by Zacks Equity Research
Helen of Troy (HELE) is benefiting from its solid Leadership Brands and a focus on Project Pegasus, while escalated costs and softness in the Beauty segment are concerns.
HELE or EL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HELE vs. EL: Which Stock Is the Better Value Option?
Nu Skin (NUS) Q4 Earnings Top Estimates, Sales Down Y/Y
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter 2022 results reflect lower revenues and earnings on macro headwinds, continued inflation and unfavorable currency.
Is Heineken (HEINY) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Heineken NV (HEINY) and Helen of Troy (HELE) have performed compared to their sector so far this year.
Helen of Troy (HELE) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
HELE or EL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HELE vs. EL: Which Stock Is the Better Value Option?
COTY Q2 Earnings Surpass Estimates, Sales Decrease Y/Y
by Zacks Equity Research
COTY second-quarter fiscal 2023 results reflect improved earnings on higher adjusted net income. However, sales fall year over year.
Clorox (CLX) Q2 Earnings and Sales Beat, Stock Rises 4.2%
by Zacks Equity Research
Clorox's (CLX) Q2 results reflect gains from strong demand trends, improved pricing, cost savings and strong execution, offset by lower volume and higher commodity costs.
Here's How Much a $1000 Investment in Helen of Troy Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Helen of Troy (HELE) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Helen of Troy (HELE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
HELE vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
HELE vs. EL: Which Stock Is the Better Value Option?
Wall Street Analysts Think Helen of Troy (HELE) Could Surge 59.4%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 59.4% in Helen of Troy (HELE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Is Albertsons Companies (ACI) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Albertsons Companies, Inc. (ACI) and Helen of Troy (HELE) have performed compared to their sector so far this year.
Helen of Troy (HELE) Troubled by Cost Woes & Soft Beauty Unit
by Zacks Equity Research
Helen of Troy (HELE) bears the brunt of escalated cost concerns and softness in the Beauty segment.
Zacks Industry Outlook Highlights Estee Lauder, Coty, Inter Parfums and Helen of Troy
by Zacks Equity Research
Estee Lauder, Coty, Inter Parfums and Helen of Troy have been highlighted in this Industry Outlook article.
4 Cosmetics Stocks Worth Watching on Robust Industry Trends
by Ansuiya Mohta
The Zacks Cosmetics industry players benefit from growing online business and focus on innovation. These factors favor The Estee Lauder Companies (EL), COTY, Inter Parfums (IPAR) and Helen of Troy (HELE).
Helen of Troy (HELE) Q3 Earnings Top Estimates, Decline Y/Y
by Zacks Equity Research
Helen of Troy's (HELE) third-quarter fiscal 2023 results reflect a decline in earnings and sales amid a tough operating landscape. However, results exceed expectations.
Helen of Troy (HELE) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 4.17% and 6.96%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?
Helen of Troy (HELE) Queued for Q3 Earnings: Things to Note
by Zacks Equity Research
Helen of Troy's (HELE) fiscal third-quarter performance will likely reflect the adverse impacts of high inflation and changing consumer buying patterns.
Helen of Troy (HELE) Soars 5.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Helen of Troy (HELE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RH (RH) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
RH (RH) delivered earnings and revenue surprises of 20.13% and 3.58%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Is Helen of Troy (HELE) Down 14.8% Since Last Earnings Report?
by Zacks Equity Research
Helen of Troy (HELE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Helen of Troy (HELE) Looks Troubled: Stock Down 25% in 3 Months
by Zacks Equity Research
Helen of Troy (HELE) has been battling escalated cost concerns and softness in its Beauty segment. Management lowered its fiscal 2023 guidance on the last earnings call.
Helen of Troy (HELE) Cuts FY23 View Despite Q2 Earnings Beat
by Zacks Equity Research
Helen of Troy's (HELE) second-quarter fiscal 2023 results reflect lower earnings. Management lowers sales and earnings guidance for fiscal 2023.
Company News for Oct 6, 2022
by Zacks Equity Research
Companies in The News Are: D, LW, VNO, HELE